Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Profound Medical Corp. (OTC: PRFMF).

Full DD Report for PRFMF

You must become a subscriber to view this report.


Recent News from (OTC: PRFMF)

Profound Medical Files Preliminary Base Shelf Prospectus
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”) announced today that it has filed and obtained a receipt for ...
Source: GlobeNewswire
Date: September, 06 2018 16:10
Profound Medical Announces Second Quarter 2018 Financial Results
TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time Magnetic Resonance (“MR”) imaging co...
Source: GlobeNewswire
Date: August, 14 2018 16:05
Profound Medical to Release Second Quarter 2018 Financial Results on August 14 - Conference Call to Follow
TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time Magnetic Resonance (“MR”) imaging co...
Source: GlobeNewswire
Date: August, 02 2018 16:30
Profound Medical to Present at the Canaccord Genuity 38th Annual Growth Conference
TORONTO, July 31, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time Magnetic Resonance (“MR”) imaging co...
Source: GlobeNewswire
Date: July, 31 2018 16:30
Profound Medical Announces Term Loan Agreement with CIBC Innovation Banking
TORONTO, July 31, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or the “Company”) (TSX:PRN) (OTCQX:PRFMF) today announced that it has entered into a term loan agreement (the “Agreement”) with the CIBC Innovation Banking (“CIBC&#...
Source: GlobeNewswire
Date: July, 31 2018 08:30
Profound Medical Corp. Announces Graduation to Toronto Stock Exchange
TORONTO, July 11, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time Magnetic Resonance (“MR”) imaging...
Source: GlobeNewswire
Date: July, 11 2018 10:10
Profound Medical Announces Annual Meeting of Shareholders Voting Results; Welcomes Two Industry Veterans as Independent Directors to its Board
TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or the “Company”)  (TSXV: PRN) (OTCQX:PRFMF) is pleased to announce the results of the votes on the matters considered at its Annual Meeting of Shareholders that was held today. &...
Source: GlobeNewswire
Date: June, 14 2018 16:30
Initial Data from Profound Medical's TACT Pivotal Clinical Trial Presented at AUA 2018
TORONTO, May 21, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time Magnetic Resonance (“MR”) imaging ...
Source: GlobeNewswire
Date: May, 21 2018 11:20
Profound Medical Corp. Announces First Quarter 2018 Financial Results
TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time Magnetic Resonance (“MR”) imaging ...
Source: GlobeNewswire
Date: May, 10 2018 16:02
Profound Medical Corp. Announces Chinese Food and Drug Administration Approval for Sonalleve®
TORONTO, May 09, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V:PRN) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time Magnetic Resonance (“MR”) imaging ...
Source: GlobeNewswire
Date: May, 09 2018 16:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.426N/AN/A0
2018-12-13N/A0.426N/AN/A0
2018-12-120.44770.4260.44770.4269,000
2018-12-110.46480.38240.46480.382433,273
2018-12-100.460.4513650.460.45136511,496

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-125009,0005.5556Cover
2018-12-1113,00033,27339.0707Short
2018-12-1010,00011,49686.9868Short
2018-12-042,61910,03526.0987Cover
2018-11-2910,92110,921100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PRFMF.


About Profound Medical Corp. (OTC: PRFMF)

Logo for Profound Medical Corp. (OTC: PRFMF)

Medical Technology

 

 

 

Current Management

  • Arun Menawat / CEO
  • Matthew Sobczyk, CPA, CA / CFO, VP, Fin.
  • Rashed Dewan / VP, Fin.
  • Damian Lamb / Chairman, Audit Committee Member
  • William Curran / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Kenneth Galbraith / Independent Director
  • Arun Menawat / Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • JeanFrancois Pariseau / Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Samira Sakhia /

Current Share Structure

  • Market Cap: $63,999,640 - 03/14/2018
  • Issue and Outstanding: 73,117,377 - 09/30/2017

 


Recent Filings from (OTC: PRFMF)

Supplemental Information - 52-109 FV2 Certificate of Interim Filings - CEO
Filing Type: Supplemental Information - 52-109 FV2 Certificate of Interim Filings - CEOFiling Source: OTC Markets
Filing Date: November, 08 2017
Supplemental Information - 52-109 FV2 Certificate of Interim Filings - CFO
Filing Type: Supplemental Information - 52-109 FV2 Certificate of Interim Filings - CFOFiling Source: OTC Markets
Filing Date: November, 08 2017
Quarterly Report - Interim Financial Statements Q3
Filing Type: Quarterly Report - Interim Financial Statements Q3Filing Source: OTC Markets
Filing Date: November, 08 2017
Management Discussion and Analysis - Management Discussion and Analysis Q3
Filing Type: Management Discussion and Analysis - Management Discussion and Analysis Q3Filing Source: OTC Markets
Filing Date: November, 08 2017

 

 


Daily Technical Chart for (OTC: PRFMF)

Daily Technical Chart for (OTC: PRFMF)


Stay tuned for daily updates and more on (OTC: PRFMF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: PRFMF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PRFMF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PRFMF and does not buy, sell, or trade any shares of PRFMF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/